Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Perrigo's $190 Mil. Personal Care Unit Going To Cumberland Swan Holdings

This article was originally published in The Tan Sheet

Executive Summary

Perrigo has signed an agreement in principle to sell its $190 mil. personal care business for an undisclosed amount to newly formed Cumberland Swan Holdings, Inc., the private labeler announced July 19. Execution of a definitive purchase agreement is expected to occur within 30 days. Proceeds will be dedicated to Perrigo's OTC and nutritional businesses.

You may also be interested in...



Leiner OTC Sales Buoy Company Performance As Supplement Market Slows

Leiner Health Products is committed to reinvigorating its struggling dietary supplement business despite the sluggish market atmosphere and the recent success of the company's growing OTC portfolio.

Leiner OTC Sales Buoy Company Performance As Supplement Market Slows

Leiner Health Products is committed to reinvigorating its struggling dietary supplement business despite the sluggish market atmosphere and the recent success of the company's growing OTC portfolio.

Leiner OTC Sales Buoy Company Performance As Supplement Market Slows

Leiner Health Products is committed to reinvigorating its struggling dietary supplement business despite the sluggish market atmosphere and the recent success of the company's growing OTC portfolio.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS090114

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel